Fatal Cryptococcus gattii genotype AFLP6/VGII infection in a HIV-negative patient: Case report and a literature review

Mycoses

Volumn 57, Issue 10, 2014, Pages 639-643

  Favalessa, Olivia Cometti ^a   Lázera, Márcia dos Santos ^b   Wanke, Bodo ^b   Trilles, Luciana ^b   Takahara, Doracilde Terumi ^a   Tadano, Tomoko ^c   Dias, Luciana Basili ^a   Vieira, Ananda Castro ^c   Novack, Glaúcia Vanessa ^c   Hahn, Rosane Christine ^a,c  

^a FEDERAL UNIVERSITY OF MATO GROSSO   (Brazil)

^b Funda??o Oswaldo Cruz   (Brazil)

^c HOSPITAL UNIVERSITÁRIO JÚLIO MÜLLER   (Brazil)

Author keywords

Cryptococcus gattii; Midwestern of Brazil; Neurocryptococcosis; Seronegative for HIV

Indexed keywords

ANTIFUNGAL AGENT;

ADULT; BRAZIL; CASE REPORT; CHILD; CRYPTOCOCCOSIS; CRYPTOCOCCUS GATTII; DRUG EFFECTS; FATALITY; FEMALE; GENETICS; GENOTYPE; HUMAN; ISOLATION AND PURIFICATION; MALE; MENINGITIS; MICROBIOLOGY; MIDDLE AGED; PRESCHOOL CHILD; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADULT; ANTIFUNGAL AGENTS; BRAZIL; CHILD; CHILD, PRESCHOOL; CRYPTOCOCCOSIS; CRYPTOCOCCUS GATTII; FATAL OUTCOME; FEMALE; GENOTYPE; HUMANS; MALE; MENINGITIS; MIDDLE AGED; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH;

EID: 84906808761     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/myc.12210     Document Type: Article

References (40)

1. Kwon-Chung KJ, Varma SA. Do major species concepts support one, two or more species within Cryptococcus neoformans? FEMS Yeast Res 2006; 6: 574-87.
2. Meyer W, Aanensen DM, Boekhout T et al. Consensus multi-locus sequence typing scheme for Cryptococcus neoformans and Cryptococcus gattii. Med Mycol 2009; 47: 561-70.
3. Favalessa OC, Ribeiro LC, Tadano T et al. Primeira descrição da caracterização fenotípica e susceptibilidade in vitro a drogas de leveduras do gênero Cryptococcus spp isoladas de pacientes HIV positivos e negativos, Estado de Mato Grosso. Rev Soc Bras Med Trop 2009; 42: 661-5.
4. Fernandes OFL, Costa TR, Costa MR, Soares AJ, Pereira AJSC, Silva MR. Cryptococcus neoformans isolados de pacientes com AIDS. Rev Soc Bras Med Trop 2000; 33: 75-78.
5. Lindenberg ASC, Chang MR, Paniago AMM et al. Clinical and epidemiological features of 123 cases of Cryptococcosis in Mato Grosso do Sul, Brazil. Rev Inst Med Trop S Paulo 2008; 50: 75-78.
6. Byrnes EJ, Li W, Lewit Y et al. Emergence and pathogenicity of highly virulent Cryptococcus gattii genotypes in the northwest United States. PLoS Pathog 2010; 6: e1000850.
7. Santos WRA, Meyer W, Wanke B et al. Primary endemic Cryptococcus gattii by molecular type VGII in the state of Pará, Brazil. Mem Inst Oswaldo Cruz 2008; 103: 813-8.
8. Trilles L, Lazéra MS, Wanke B et al. Regional pattern of the molecular types of Cryptococcus neoformans and Cryptococcus gattii in Brazil. Mem Inst Oswaldo Cruz 2008; 103: 455-62.
9. Chen SC, Korman TM, Slavin MA et al. Australia and New Zealand Mycoses Interest Group (ANZMIG) Cryptococcus Study. Antifungal therapy and management of complications of cryptococcosis due to Cryptococcus gattii. Clin Infect Dis 2013; 57: 543-51.
10. Matsumoto MT, Fusco-Almeida AM, Baeza LC, Melhem MSC, Mendes-Giannini MJS. Genotyping, serotyping and determination of mating-type of Cryptococcus neoformans clinical isolates from São Paulo State, Brazil. Rev Inst Med Trop S Paulo 2007; 49: 41-47.
11. Silva PR, Rabelo RAS, Terra APS, Teixeira DNS. Suscetibilidade a antifúngicos de variedades de Cryptococcus neoformans isoladas de pacientes em hospital universitário. Rev Soc Bras Med Trop 2008; 41: 158-62.
12. Pinto Junior VL, Pone MVS, Pone SM et al. Cryptococcus gattii molecular type VGII as agent of meningitis in a healthy child in Rio de Janeiro, Brazil: report of an autochthonous case. Rev Soc Bras Med Trop 2010;43:746-8.
13. Mitchel DH, Sorrell T, Allworth AM et al. Cryptococcal disease of the CNS in immunocompetent host: influence of cryptococcal variety on clinical manifestations and outcome. Clin Infect Dis 1995; 20: 611-6.
14. Perfect JR, Dismukes WE, Dromer F et al. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of America. Clin Infect Dis 2010; 50: 291-322.
15. Chong HS, Dagg R, Malik R, Chen S, Carter D. In vitro susceptibility of the yeasts pathogen Cryptococcus to fluconazole and other azoles varies with molecular genotype. J Clin Microbiol 2010; 48: 41.
16. Sar B, Monchy D, Vann M, Keo C, Sarthou JL, Buisson Y. Increasing in vitro resistance to fluconazole in Cryptococcus neoformans Cambodian isolates: April 2000 to March 2002. J Antimicrob Chemother 2004; 54: 563-5.
17. Souza LK, Souza Junior AH, Costa CR et al. Molecular typing and antifungal susceptibility of clinical and environment Cryptococcus neoformans species complex isolates in Goiania, Brazil. Mycoses 2009;53:62-67.
18. Gutierrez EL, Valqui W, Vilchez L et al. Cryptococcus gattii meningoencephalitis in an HIV-negative patient from the Peruvian Andes. Rev Soc Bras Med Trop 2010; 43: 469-71.
19. Soares BM, Santos DA, Kohler LM et al. Cerebral infection caused by Cryptococcus gattii: a case report and antifungal susceptibility testing. Rev Iberoam Micol 2008; 25: 242-5.
20. Oliveira FM, Severo CB, Guazzelli LS, Severo LC. Cryptococcus gattii fungemia: report of a case with lung and brain lesions mimicking radiological features of malignancy. Rev Inst Med Trop S Paulo 2007; 49: 263-5.
21. Hagen F, Ceresini PC, Polacheck I et al. Ancient dispersal of the human fungal pathogen Cryptococcus gattii from the Amazon rainforest. PLoS ONE 2013; 8: e71148.
22. Kidd SE, Hagen F, Tscharke RL et al. A rare genotype of Cryptococcus gattii caused the Cryptococcosis outbreak on Vancouver Island (British Columbia, Canada). Proc Natl Acad Sci USA 2004;101:17258-63.
23. Fraser JÁ, Giles SS, Wenink EC et al. Same-sex mating and the origin of the Vancouver Island Cryptococcus gattii outbreak. Nature 2005; 437: 1360-1364 6.
24. Fortes ST, Lazera MS, Nishikawa MM, Macedo RC, Wanke B. First isolation of Cryptococcus neoformans var. gattii from native jungle tree in the Brazilian Amazon rainforest. Mycoses 2001; 44: 137-40.
25. Chowdhary A, Randhawa HS, Prakash A, Meis JF. Environmental prevalence of Cryptococcus neoformans and Cryptococcus gattii in India: an update. Crit Rev Microbiol 2012; 38: 1-16.
26. Hagen F, Colom MF, Swinne D et al. Autochthonous and dormant Cryptococcus gattii infections in Europe. Emerg Infect Dis 2012; 18: 1618-24.
27. Anzai MC, Lazera MS, Wanke B et al. Cryptococcus gattii in a Plathymenia reticulata hollow in Cuiabá, Mato Grosso, Brazil. Mycoses 2014; 57: 1-7.
28. Casali AK, Goulart L, Rosa e Silva LK et al. Molecular typing of clinical and environmental Cryptococcus neoformans isolates in the Brazilian state Rio Grande do Sul. FEMS Yeast Res 2003; 3: 405-15.
29. Lazéra MS, Wanke B, Nishikawa MM. Isolation of both varieties of Cryptococcus neoformans var. neoformans from saprophytic sources in the city of Rio de Janeiro, Brazil. J Med Vet Mycol 1993; 31: 449-54.
30. Hagen F, Illnait-Zaragozi MT, Bartlett KH et al. In vitro antifungal susceptibilities and amplified fragment length polymorphism genotyping of a worldwide collection of 350 clinical, veterinary, and environmental Cryptococcus gattii isolates. Antimicrob Agents Chemother 2010; 54: 5139-45.
31. Tay ST, Haryanty TT, Ng KP, Rohani MY, Hamimah H. In vitro susceptibilities of Malaysian clinical isolates of Cryptococcus neoformans var. grubii and Cryptococcus gattii to five antifungal drugs. Mycoses 2006; 49: 324-30.
32. Thompson GR, Wiederhold NP, Fothergill AW, Vallor AC, Wickes BL, Patterson TF. Antifungal susceptibilities among different serotypes of Cryptococcus gattii and Cryptococcus neoformans. Antimicrob Agents Chemother 2009; 53: 309-11.
33. Iqbal N, DeBess EE, Wohrle R et al., for the Cryptococcus gattii Public Health Working Group. Correlation of genotype and in vitro susceptibilities of Cryptococcus gattii strains from the Pacific Northwest of the United States. J Clin Microbiol 2010;48:539-44.
34. Rufino BB, Swinne D. Aislamiento de Cryptococcus neoformans variedad gattii en dos pacientes peruanos. Rev Iberoam Micol 1998; 15: 22-24.
35. Colom FM, Frases S, Ferrer C et al. First case of human Cryptococcosis due to Cryptococcus neoformans var. gattii in Spain. J Clin Microbiol 2005; 43: 3548-50.
36. Levy R, Pitout J, Long P, Gill JM. Late presentation of Cryptococcus gattii meningitis in a traveller to Vancouver Island: a case report. Can J Infect Dis Med Microbiol 2007; 18: 197-9.
37. Bromilow J, Corcoran T. Cryptococcus gattii infection causing fulminante intracranial hypertension. Britsh J anesthesiol 2007; 99: 528-31.
38. Georgi A, Schneemann M, Tintelnot K et al. Cryptococcus gattii meningoencephalitis in an immunocompetent person 13 months after exposure. Infection 2009; 37: 370-2.
39. Debourgogne A, Hagen F, Elenga N et al. Successful treatment of Cryptococcus gattii neurocryptococcosis in a 5-year-old immunocompetent child from the French Guiana Amazon region. Ver Iberoam Micol 2012; 29: 210-3.
40. Illnat-Zaragozi MT, Ortega-Gonzalez LM, Hagen F, Martinez-Machin GF, Meis JF. Fatal Cryptococcus gattii genotype AFLP5 infection in an immunocompeten Cuban patient. Med Mycol Case Reports 2013; 2: 48-51.